In the same quarter last year, the country had recorded investments of USD 2.56 billion across 243 deals
The combined company is expected to have 2017 pro forma net revenue ranging from USD 1.75 billion to USD 1.85 billion and pro forma adjusted EBITDA of approximately USD 600 million to USD 650 million in 2017 and USD 700 million to USD 750 million in 2018, each including USD 80 million to USD 120 million of annualized cost savings within the first full year of close.
IndusInd Bank on Saturday confirmed its acquisition of microfinance institution Bharat Financial Inclusion after over a month of exclusive merger arrangement. In an interview to CNBC-TV18, Digant Haria of Antique Stock Broking and Santosh Singh of Haitong Securities shared their views and reading on the deal and the stocks.
IndusInd Bank on Saturday confirmed its acquisition of microfinance institution Bharat Financial Inclusion after over a month of exclusive merger arrangement. CNBC-TV18's Kevin Lee caught up with Bharat Financial's MD & CEO, MR Rao.
The life insurer had reported profit of Rs 300 crore last fiscal. The overall networth of the business stood at Rs 1,825 crore as of March 2017.
The wave of consolidation continues in the telecom space. Tata Teleservices (Maharashtra) will merge with India's top service provider Bharti Airtel in a "debt-free" and "cash-free" deal.
Lupin on Wednesday has agreed to buy US-based Symbiomix Therapeutics for USD 150 million. The drug maker will be doing several deals in the coming quarters.
As part of the deal, Airtel will assume a small portion of the unpaid spectrum liability of Tata Teleservices.
Lupin acquired American firm Symbiomix Therapeutics for USD 150 million. The company says they expect significant cash flows from the deal in the next three years. In an interview to CNBC-TV18, Ramesh Swaminathan, CFO & ED of Lupin spoke at length about the acquisition, numbers and his outlook going ahead.
PepsiCo India is planning to sell its bottling operations in the west and south to franchisees, thereby exiting that part of its business across the country.
Both companies have submitted binding offers and are currently in negotiations with Videocon's management to enter exclusive talks for a deal.
Shoppers Stop is buzzing in trade today. CNBC-TV18 learns that Future Retail set to acquire supermarket chain, HyperCity today. The deal likely to be valued around Rs 600-700 crore.
One of the biggest financial merger deals in the country, IDFC with Shriram Group, has hit a hurdle after it faced opposition from some of its shareholders.
Karnataka Bank is in focus after the bank called for a board meeting to appoint consultants to explore transformational opportunities. In an interview to CNBC-TV18, Mahabaleshwara MS, MD & CEO of Karnataka Bank spoke at length about the same and his outlook going ahead.
Loerop will lead Lupin's overall corporate development efforts and will be responsible for the Company's global mergers and acquisitions and business development functions, Lupin said in a statement.
The company has posted a revenue of Rs 2.42 lakh crore and a profit of Rs 8,000 crore for the financial year 2017
According to Nigam, the consumption patterns are shifting from back office to front, and the IT is revenue enabler and therefore the consumption of solutions would be smaller in nature
The 46 percent decline in August M&A value was primarily due to the absence of big ticket transactions.
IndusInd Bank has signed an exclusive agreement with micro-finance lender Bharat Financial Inclusion to explore a possible merger.
IndusInd Bank and RBL Bank are the two remaining potential buyers in the race to acquire the micro-finance company and are in talks with investment bank Credit Suisse, which has been appointed by Bharat Financial Inclusion for the purpose.
The one deal that everyone is talking about is Bharat Financial Inclusion. Is it on, it is not, who are the players? Watch accompanying video of CNBC-TV18's Prashant Nair with some number crunching that he did on the stock movement and valuations.
In an interview to CNBC-TV18, Nidhesh Jain, Analyst at Investec Capital Services shared his views on non banking financial companies (NBFCs) and also spoke about the deal in the making - IndusInd Bank and Bharat Financial Inclusion.
The drug maker, besieged by pricing pressures and regulatory problems at its facilities, is looking to sell its oral penicillin manufacturing site in Bristol, US and brands such as Augmentin, Amoxil and other penicillin abbreviated new drug applications (ANDAs).
The British company's chief executive James Kidd said he was confident the merger would get over the line this time after two failed attempts to do a deal since 2015.